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particular type of exercise could help coaches/practition-
ers individualise the exercise training of their athletes/
patients, thus maximising recovery and adaptation, while 
reducing overload-associated injury risk. The purpose 
of this review is to provide a critical analysis of the lit-
erature concerning gene polymorphisms associated with 
exercise-induced muscle damage, both in young and 
older individuals, and to highlight the potential mecha-
nisms underpinning these associations, thus providing a 
better understanding of exercise-induced muscle damage.
Keywords Exercise-induced muscle damage · Delayed 
onset muscle soreness · Single nucleotide polymorphism · 
Creatine kinase · Elderly
Abbreviations
ACE  Angiotensin-I converting enzyme
ACTN3  Gene that encodes the α-actinin-3 protein
CCL2  Chemokine (C–C motif) ligand-2
CCR2  Chemokine (C–C motif) receptor type-2
CK  Creatine kinase
COL  Gene that encodes the collagen protein
IGF  Insulin-like growth factor
IL  Interleukin
mRNA  Messenger ribonucleic acid
MyoD  Myogenic differentiation factor
NF-κB  Nuclear factor kappa-light-chain-enhancer of 
activated B cells
Pax7  Paired box protein-7
ROS  Reactive oxygen species
SLC30A8  Gene that encodes the solute carrier family 30 
(zinc transporter) member eight protein
SNP  Single nucleotide polymorphism
TNF  Tumour necrosis factor
Abstract Prolonged unaccustomed exercise involv-
ing muscle lengthening (eccentric) actions can result in 
ultrastructural muscle disruption, impaired excitation–
contraction coupling, inflammation and muscle protein 
degradation. This process is associated with delayed 
onset muscle soreness and is referred to as exercise-
induced muscle damage. Although a certain amount 
of muscle damage may be necessary for adaptation to 
occur, excessive damage or inadequate recovery from 
exercise-induced muscle damage can increase injury 
risk, particularly in older individuals, who experience 
more damage and require longer to recover from muscle 
damaging exercise than younger adults. Furthermore, it 
is apparent that inter-individual variation exists in the 
response to exercise-induced muscle damage, and there 
is evidence that genetic variability may play a key role. 
Although this area of research is in its infancy, certain 
gene variations, or polymorphisms have been associated 
with exercise-induced muscle damage (i.e. individu-
als with certain genotypes experience greater muscle 
damage, and require longer recovery, following strenu-
ous exercise). These polymorphisms include ACTN3 
(R577X, rs1815739), TNF (−308 G>A, rs1800629), IL6 
(−174 G>C, rs1800795), and IGF2 (ApaI, 17200 G>A, 
rs680). Knowing how someone is likely to respond to a 
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Introduction
People who engage in unaccustomed, strenuous physical 
exercise can experience stiff or sore muscles, a feeling that 
is usually apparent for 24–72 h after exercise. This phe-
nomenon is known as delayed onset muscle soreness. Sev-
eral investigations have revealed that these unaccustomed 
eccentric actions, during which the muscle is lengthened 
while it is active, provoke stiffer and more tender muscles 
compared to concentric or isometric contractions (Arm-
strong 1984; Armstrong et al. 1991). These contractions are 
strongly associated with damage to skeletal muscle consist-
ing of structural disruption of sarcomeres, disturbed excita-
tion–contraction coupling and calcium signalling, leading 
to an inflammatory response and the activation of several 
muscle protein degradation pathways. This process has 
been referred to as exercise-induced muscle damage (Hyl-
dahl and Hubal 2014; Peake et al. 2005) and is normally 
accompanied by swelling, and a temporary reduction in 
both maximum strength and range of motion (Baird et al. 
2012; Brown et al. 1999; Clarkson et al. 1992). Circulating 
muscle-specific proteins [e.g., creatine kinase (CK), myo-
globin and α-actin] are commonly used to indicate exer-
cise-induced muscle damage (Huerta-Alardín et al. 2005; 
Martinez Amat et al. 2007), whereas tenascin-C is thought 
to be an indicator for disruption of the overlying connective 
tissue and the extracellular matrix (Flück et al. 2003).
Exercise-induced muscle damage can be divided into 
the initial damage phase, which occurs during the exercise 
bout, and the secondary damage phase, which is linked 
with the delayed inflammatory response (Kuipers 1994; 
Howatson and Van Someren 2008). These phases are even-
tually followed by muscle remodelling (Flann et al. 2011; 
Thiebaud 2012; Tidball 2005). Although there is evidence 
to suggest that a certain amount of muscle damage is a 
positive stimulus for muscle restructuring, hypertrophy 
and strength gains (Roig et al. 2008), in rare cases, strenu-
ous unaccustomed exercise can lead to exertional rhabdo-
myolysis, which is characterised by muscle fibre necrosis 
(Warren et al. 2002b). Intracellular muscle contents leak 
into the circulation and extracellular fluid, which can lead 
to kidney failure or even to death (Knochel 1990; Clarkson 
et al. 2005b). Furthermore, the response to muscle damage 
seems to be age-dependent. There is evidence to suggest 
that older people are more susceptible to muscle damage 
compared to young adults, which is reflected by impaired 
muscle regeneration and hampered remodelling (Conceição 
et al. 2012; Peake et al. 2010; Snijders et al. 2009).
From the plethora of studies that have investigated exer-
cise-induced muscle damage, it is apparent that variability 
in the response to muscle damaging exercise exists between 
(Vincent et al. 2010; Clarkson et al. 2005b) and within 
studies (Nosaka and Clarkson 1996). Variations between 
studies can occur due to different study population, age, 
gender and a small sample size (Eynon et al. 2013; Toft 
et al. 2002). However, intra-study variation within a 
homogenous cohort warrants further consideration, with 
evidence to suggest that genetic variability may play a role. 
Some genes have common variations in sequence, known 
as polymorphisms, which, depending on where this poly-
morphism occurs within the gene, can directly affect gene 
expression and ultimately the amount of protein produced. 
The most common type of sequence variation is a single 
nucleotide polymorphism (SNP), where one nucleotide 
substitutes another. Another type of common sequence 
variation is the insertion/deletion (indel) polymorphism, 
in which a specific nucleotide sequence is present (inser-
tion) or absent (deletion) from the allele. Some polymor-
phisms can modify the protein product, thus potentially 
altering function. It follows, therefore, that polymorphisms 
of genes encoding key proteins in the muscle–tendon unit 
(such as the ACTN3 R577X SNP) have implications for the 
ability to recover from strenuous exercise, thus influencing 
the risk of injury. This may be particularly relevant in elite 
athlete groups, who are known to have different genetic 
profiles compared to the general population (Yang et al. 
2003; Myerson et al. 1999). Moreover, specific gene poly-
morphisms (e.g. COL1A1 rs1800012, COL5A1 rs12722, 
rs3196378, MMP3 rs679620, rs591058 and rs650108) have 
been associated with tendon/ligament injury prevalence 
(e.g., Achilles tendinopathy/rupture and anterior cruciate 
ligament rupture) (Bell et al. 2012; Laguette et al. 2011; 
Collins and Raleigh 2009). However, very little is known 
about the potential genetic association with muscle damage 
and muscle regeneration in response to muscle damaging 
exercise, either in young or older people, or the mecha-
nisms that underpin that association.
As older people appear to be more susceptible to exer-
cise-induced muscle damage than younger adults (Jiménez-
Jiménez et al. 2008; Manfredi et al. 1991; Fielding et al. 
1991; Roth et al. 2000), older people with a genetic predis-
position to greater muscle damage, may be at a greater risk 
of developing muscle–tendon unit injury (Laguette et al. 
2011; September et al. 2007). As a result, these individuals 
may experience prolonged disuse and therefore increased 
ageing-associated muscle atrophy (i.e., sarcopaenia), which 
is associated with reductions in strength and quality of life. 
Knowing who requires longer to recover from a bout of 
strenuous exercise, may help practitioners prescribe per-
sonalised exercise medicine to their patients, thus optimis-
ing health and reducing the risk of injury and further mus-
cle wasting. One of the greatest challenges facing exercise 
genetic research is the investigation of functionally relevant 
genetic variation and of their mechanisms of action. The 
aims of this review are to (1) provide a critical review of 
the current literature on exercise-induced muscle damage 
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and, therefore, to improve our understanding of the differ-
ent phases of the responses to muscle damaging exercise; 
(2) emphasise those studies that have investigated the asso-
ciation between genetic variation and muscle damage, both 
in young and older people; and (3) propose mechanistic 
explanations that may underpin these associations.
Genetic variation and the initial phase 
of exercise‑induced muscle damage
Exercise-induced muscle damage can result in damage 
to the ultrastructure of the muscle fibre (including Z-line 
streaming), to the extracellular matrix, and to overextended 
sarcomeres and t-tubules of skeletal muscle tissue (Brown 
et al. 1997b; Kjær 2004; Friden and Lieber 1992, 2001; 
Friden et al. 1981). Structural disruption of sarcomeres is 
thought to be caused by the heterogeneity of sarcomere 
length (Morgan 1990) and, consequently, some sarcom-
eres resist eccentric actions more than others (Allen et al. 
2005; Friden et al. 1981). Prolonged strain causes weaker 
sarcomeres to be stretched beyond the optimum overlap of 
actin and myosin filaments (Fig. 1). This results in popped 
sarcomeres and appears as a broadening, smearing or even 
disruption of the Z-lines. Interestingly, the thinnest Z-lines 
are detected in the faster (type II) muscle fibres, which 
generate the highest shortening velocities, and the widest 
Z-lines are found in slow (type I) muscle fibres (Knoll et al. 
2011). Consequently, fast-twitch fibres are more sensitive 
than slow twitch fibres to Z-disk streaming (Proske and 
Morgan 2001; Appell et al. 1992). This mechanical damage 
is one mechanism by which a prolonged loss of strength 
occurs immediately after excessive strain (Cheung et al. 
2003; Hyldahl and Hubal 2014; Friden and Lieber 1992).
The transmission of muscle fibre force to the tendon 
(leading to joint movement) occurs not only in the longi-
tudinal direction in line with the direction of pull of the 
tendon, but also in the lateral direction (between adjacent 
fibres to the overlying connective tissue and extracellular 
matrix) (Kjær 2004; Hughes et al. 2015). The extracellular 
matrix in skeletal muscle provides structural and biochemi-
cal support to the contractile tissue, and is associated with 
the inflammatory response and satellite cell activation (see 
“Skeletal muscle remodelling following exercise-induced 
Fig. 1  Initial phase of exercise-induced muscle damage. Due to dif-
ferent abilities of each sarcomere to resist eccentric actions, some 
of the sarcomeres will be stretched beyond the optimum overlap of 
actin and myosin filaments, resulting in Z-line streaming (Morgan, 
1990) (1). This is accompanied by increased permeability of the 
sarcolemma (2). Extracellular Ca2+ influx into the muscle fibre acti-
vates different Ca2+-sensitive proteases (calpains). Calpain activation 
leads to proteolysis of cytoskeletal and costameric proteins (Thiebaud 
2012) (3). However, a failure of excitation–contraction coupling also 
seems to play an important role in strength loss following strenuous 
exercise, as murine muscle exposed to caffeine revealed an attenuated 
loss of muscle strength (Warren et al. 1993) (4). Figure adapted from 
Hyldahl and Hubal (2014)
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muscle damage”) (Hyldahl and Hubal 2014; Kjær 2004). 
The relative proportion of different collagen subtypes in 
the extracellular matrix of skeletal muscle and tendon var-
ies depending on the position and function of the connect-
ing tissues (Kjær 2004; Duance et al. 1977; Davis et al. 
2013). The contractile apparatus is connected to the extra-
cellular matrix by costameres (structural complexes com-
prising proteins such as dystrophin, focal adhesion kinase 
and integrins) and by intermediate filament proteins, such 
as desmin (Hughes et al. 2015). According to Ramaswamy 
et al. (2011), more than 80 % of muscle force is transferred 
via this lateral pathway. Thus, costameres, intermediate fil-
ament proteins and the extracellular matrix are considered 
essential for the integrity of skeletal muscle and the main-
tenance of lateral force transmission. Furthermore, they 
are thought to play an important role in injury prevention 
by stabilising the myofilaments (Lovering and De Deyne 
2004; Stauber et al. 1990; Hughes et al. 2015). The degra-
dation of cytoskeletal, costameric and extracellular matrix 
proteins could negatively influence the lateral transmis-
sion of force between adjacent muscle fibres, which could, 
at least in part, be the source of the prolonged decrease 
of maximum strength seen following strenuous exercise 
(Raastad et al. 2010).
Activation of Ca2+ proteases (calpains) appears to play 
an important part in the muscle damage–repair process. 
Damage to the sarcolemma results in the accumulation of 
excess intracellular Ca2+, which activates different calcium-
sensitive proteases, localised predominantly at the I band 
and Z disk regions of myofibrils (Belcastro et al. 1998). The 
activation results in proteolysis within minutes of cytoskel-
etal and costameric proteins (Thiebaud 2012; Lovering and 
De Deyne 2004; Boppart et al. 2008; Zhang et al. 2008; 
Allen et al. 2005), and calpain activity is still measurable 
three days after exercise-induced muscle damage (Raastad 
et al. 2010). This intra- and extracellular damage requires 
the removal and repair of the damaged proteins, and is there-
fore followed by an inflammatory response and by activa-
tion of the ubiquitin–proteasome pathway (see “Genetic var-
iation and the secondary phase of exercise-induced muscle 
damage”) (Wei et al. 2005; Tidball 2005). However, the loss 
of strength after eccentric muscle contractions was reversed 
by exposing murine muscle to caffeine (Balnave and Allen 
1995; Warren et al. 1993). Caffeine facilitates the influx of 
free intracellular Ca2+ from sarcoplasmic reticulum into the 
cytosol of the muscle (Warren et al. 1993; Proske and Mor-
gan 2001). This phenomenon cannot be explained by dam-
age to the sarcomere, so it can be concluded that sarcomere 
damage is not the only cause of strength loss, as impaired 
ECC also appears to play a role (Cheung et al. 2003; Hyl-
dahl and Hubal 2014). Increased permeability of the sarco-
lemma, due to damaged muscle fibre structure, metabolic 
disturbance, and fibre remodelling, is likely to be the main 
reason for elevated plasma CK and myoglobin (Kjær 2004; 
Baird et al. 2012).
A repeated bout of the same eccentric exercise causes 
significantly fewer symptoms, such as a lower sensation 
of pain and almost no increase in serum CK activity plus 
faster recovery of muscle function (Brown et al. 1997a). 
This well-established phenomenon is referred to as the 
repeated bout effect and can last up to six months (Nosaka 
et al. 2001). A repeated bout of strength training results 
in a different expression of genes, which are involved in 
pro- and anti-inflammatory responses, leading to reduced 
inflammation (Gordon et al. 2012). There is also evidence 
that the repeated bout effect, at least in part, is based on 
restructuring of the muscle after damage (McHugh 2003). 
Likewise, extracellular matrix remodelling is believed to be 
associated with protection of skeletal muscle against future 
damage, which is indicated by an increase in gene expres-
sion of collagen types I and III and laminin-β2 (Mackey 
et al. 2011). This is thought to occur in line with muscle 
remodelling of intermediate filaments and the addition of 
sarcomeres in series (leading to longer fibres) (Friden et al. 
1984; Armstrong 1990; Hyldahl and Hubal 2014).
Considering all of the above, candidate SNPs influenc-
ing the initial phase of contraction-induced damage are 
likely to be functional SNPs of genes encoding key struc-
tural proteins within the sarcomere, the extracellular matrix 
and the costameric protein complexes linking the two. The 
following sections will highlight the evidence to support 
this hypothesis. Table 1 summarises every candidate SNP 
that has been discussed in this review.
Alpha‑actinin‑3 R577X polymorphism and the initial 
phase of exercise‑induced muscle damage
Of all the polymorphisms that have been associated with 
exercise-induced muscle damage, the most investigated is 
the ACTN3 R577X SNP (Clarkson et al. 2005b; Deuster 
et al. 2013; Pimenta et al. 2012; Seto et al. 2011; Venckunas 
et al. 2012; Vincent et al. 2010) (Table 1). The protein iso-
forms, α-actinin-2 and α-actinin-3, are crucial components 
of the Z-line in mammalian skeletal muscle and anchor 
actin filaments to the Z-lines, cross-linking the thin fila-
ments to the adjacent sarcomeres (Mills et al. 2001; North 
et al. 1999; Blanchard et al. 1989). Whilst α-actinin-2 is 
ubiquitously expressed in skeletal muscle, α-actinin-3 is 
only expressed in fast-twitch fibres of human skeletal mus-
cle (North and Beggs 1996; North et al. 1999). A functional 
SNP (rs1815739; substitution of a C with a T nucleotide) 
results in an abortive stop codon (X-allele) rather than the 
expression of the amino acid arginine (R-allele) at amino 
acid 577 of exon 16 on chromosome 11, resulting in an 
individual being either RR, RX or XX genotype. As a con-
sequence, XX homozygotes are not able to express the 
Eur J Appl Physiol 
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protein α-actinin-3 (MacArthur and North 2004; North 
and Beggs 1996; North et al. 1999). A sub-section of the 
population is XX homozygous, ranging from less than 1 % 
in African Bantus to 18 % in Europeans, to 25 % in Asian 
populations (Mills et al. 2001). Absence of α-actinin-3 does 
not result in a disease phenotype due to compensatory up-
regulation of α-actinin-2 (North et al. 1999) but there is evi-
dence that this nonsense SNP affects physical performance 
(Erskine et al. 2014; Niemi and Majamaa 2005; Clarkson 
et al. 2005a; Moran et al. 2007).
The ACTN3 XX genotype has been associated with 
smaller muscle volume (Erskine et al. 2014), slower base-
line sprint times (Niemi and Majamaa 2005; Moran et al. 
2007), lower strength (Erskine et al. 2014; Clarkson et al. 
2005a), and lower muscle power (Clarkson et al. 2005a; 
Seto et al. 2011; Walsh et al. 2008; Moran et al. 2007; 
Erskine et al. 2014). These findings are supported by Actn3 
knock-out mouse models, demonstrating a shift in the 
properties of fast muscle fibres towards a more oxidative 
fast fibre profile, lower muscle strength, reduced mass and 
decreased diameter of IIb fibres (Chan et al. 2011; MacAr-
thur et al. 2007, 2008). Strong evidence has been presented 
that, as a consequence of the up-regulation of α-actinin-2 in 
XX homozygotes, more calsarcin-2 is bound to α-actinin-2 
and less to calcineurin (Seto et al. 2013). The binding affin-
ity of calsarcin-2, which functions as an inhibitor of cal-
cineurin activation, is greater for α-actinin-2 compared to 
α-actinin-3. Consequently, a higher level of free calcineu-
rin is able to activate the downstream signalling of the 
slow myogenic programme. Given the larger size, higher 
force and power generating capacity, and lower fatigue 
resistance of type II fibres compared to type I fibres (Bot-
tinelli et al. 1996), the evidence presented by Seto et al. 
(2013) provides a mechanistic explanation for the associa-
tions between ACTN3 genotype and muscle size, strength, 
power, and endurance phenotypes.
Recent investigations have suggested that α-actinin-3 
may be evolutionarily optimised for the minimization of 
muscle damage (Yang et al. 2003). The majority of the 
human studies support the hypothesis that XX homozy-
gotes are more susceptible to strenuous exercise com-
pared to their RR or RX counterparts (Pimenta et al. 2012; 
Vincent et al. 2010; Deuster et al. 2013). For instance, 
ACTN3 XX homozygotes are approximately three times 
more likely to develop exertional rhabdomyolysis com-
pared to people of RR or RX genotypes (Deuster et al. 
2013). However, other studies have revealed no differences 
between ACTN3 genotypes regarding markers of muscle 
damage (Clarkson et al. 2005b), or have shown contrary 
effects post-exercise (Venckunas et al. 2012) or in muscle 
injury risk (Iwao-Koizumi et al. 2014). The cross-sectional 
study of Clarkson et al. (2005b) revealed no differences in 
strength loss but a lower baseline CK activity in the blood 
in ACTN3 XX homozygotes compared to carriers of the 
ACTN3 R-allele. These baseline differences in CK activity 
may have been due to ACTN3 genotype-dependent differ-
ences in muscle mass (i.e., smaller muscle volume in XX 
homozygotes versus R-allele carriers) (Erskine et al. 2014).
Movements with repeated stretch–shortening cycles, 
eccentric followed by immediate concentric muscle con-
traction) (Venckunas et al. 2012) seem to have a different 
demand profile for the muscle–tendon unit compared to 
purely eccentric actions (Fig. 2) (Seto et al. 2011; Vincent 
et al. 2010). Due to the fact that α-actinin is linked to both 
the longitudinal and lateral transmission of force (Hughes 
et al. 2015; Yang and Xu 2012), we propose that α-actinin-3 
deficiency (XX genotype) with a more elastic Z-line (Broos 
et al. 2012) might result in benefits to stretch–shortening 
cycle movements compared to R-allele carriers. Although 
stretch–shortening cycle includes an eccentric element, 
contrary to the type of maximal eccentric contractions typi-
cally used in exercise-induced muscle damage studies, the 
force and the eccentric phase involved in the active braking 
phase of stretch–shortening cycles are generally fast and 
of short duration (Nicol et al. 2006). Interestingly, muscle 
activation decreases with increasing velocity in the eccen-
tric phase under the stretch–shortening cycle conditions 
(Benoit and Dowling 2006), which indicates that other 
non-contractile (elastic) structures, such as the extracellu-
lar matrix/tendon, might provide important contribution to 
the power output by storing energy (Kjær 2004; Yang and 
Xu 2012). Indeed, a highly compliant elastic musculoten-
dinous system is thought to elevate the use of elastic strain 
energy in stretch–shortening cycle movements (Wilson 
et al. 1991). Thus, individually performed eccentric actions 
with greater longitudinal force transmission might damage 
the link between the contractile structure and the Z-line, 
which might activate the calpain system to a greater extent.
The transmission of muscle fibre force to the ten-
don may occur faster by the stiffer Z-line including 
α-actinin-3 in the longitudinal direction (Hughes et al. 
2015; Broos et al. 2012) and, also, might reduce muscle 
damage in eccentric actions performed without a stretch–
shortening cycle compared to the α-actinin-3 deficient 
fibres (Seto et al. 2011; Vincent et al. 2010). Head et al. 
(2015) revealed a significantly increased sarcoplasmic 
reticulum Ca2+ pumping and leakage in ACTN3 XX 
homozygotes, which was probably due to a higher expres-
sion of the specific Ca2+ channel sarco(endo)plasmic 
reticulum calcium-adenosine-triphosphatase-1 gene, and 
of the Ca2+ binding proteins, calsequestrin and sarcalu-
menin, in the sarcoplasmic reticulum (Head et al. 2015). 
Increased dynamics with elevated intracellular Ca2+ lev-
els during and after exertional muscle damage may lead 
to increased cytoskeletal damage and membrane disrup-
tion (Zhang et al. 2008; Head et al. 2015; Quinlan et al. 
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2010). Muscle damage induced by exclusively performed 
eccentric actions might lead to increased desmin deg-
radation (Yu 2013), which results in fewer connections 
with the extracellular matrix and adjacent myofibrils, 
and could be an explanation for the higher susceptibil-
ity of XX homozygotes in this mode of exercise. Taken 
together, the different effect of the ACTN3 R577X SNP 
in diverse mode of exercises could explain the fact that 
studies show mixed results. This may be why there are 
differences in ACTN3 genotype frequency in short and 
long distance athletes of stretch–shortening cycle-related 
sports (e.g., running) (Yang et al. 2003), whereas both 
short and long distance athletes in power sports, com-
monly carried out without stretch–shortening cycles 
(e.g., swimming), show no difference in genotype/allele 
frequency distribution (Ben-Zaken et al. 2015). This 
demonstrates why future studies should not only distin-
guish between power and endurance athletes, but should 
focus on sport-specific movements when investigating 
the association with genetic variation.
Fig. 2  Proposed changes in sarcomere structure during stretch–
shortening cycle movements and purely eccentric actions, focus-
sing on α-actinin (highlighted in red and underlined). The left-hand 
side shows the sarcomere longitudinally in a quasi-3D model at 
rest, and the α-actinin elongation during purely eccentric actions, 
and stretch–shortening cycle movements (1). The right-hand side 
illustrates the sarcomere cross-section at the level of the Z-line (2). 
At rest, α-actinin is set to roughly 90° between the antiparallel actin 
filaments, while under active tension, the space between the antipar-
allel actin filaments increases and α-actinin is stretched to a basket-
weave lattice (Gautel 2011). Alpha-actinin is thought to play a key 
role in the longitudinal (via the anchoring of actin filaments to the 
Z-line) and lateral (via costamere fibre-to-fibre interaction) transmis-
sion of muscle fibre force (Hughes et al. 2015; Yang and Xu 2012). 
Moreover, human type II muscle fibres from ACTN3 XX homozy-
gotes (where α-actinin-3 deficiency is compensated by the presence 
of α-actinin-2) are less stiff than type II muscle fibres from ACTN3 
R-allele carriers (Broos et al. 2012). Thus, it is likely that α-actinin-2 
is able to store more energy than α-actinin-3 during the active stretch 
phase of the stretch–shortening cycle, which is released during the 
shortening phase (Kjær 2004; Yang and Xu 2012). We propose that 
stretch–shortening cycle movements increase the actin filament spac-
ing to a greater extent compared to purely eccentric actions, thus 
elongating α-actinin to become almost completely straight at peak 
eccentric force. Individuals with α-actinin-3 deficiency (ACTN3 XX 
homozygotes) might, therefore, benefit from having a more elas-
tic Z-line during stretch–shortening cycle movements compared to 
R-allele carriers (Broos et al. 2012), resulting in a reduced damage 
response to stretch–shortening movements (Venckunas et al. 2012). 
Figure adapted from Gautel (2011) (color figure online)
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Myosin light chain kinase polymorphisms and the 
initial phase of exercise‑induced muscle damage
Every myosin head is connected with two light chains on 
the long lever arm, which are known as the essential and 
the regulatory light chains. In skeletal and cardiac mus-
cles of mammals, troponin and tropomyosin have the role 
of triggering the contraction following the increase in free 
cytosolic Ca2+, while the regulatory light chain modulates 
Ca2+ activation (Sweeney et al. 1993; Cheung et al. 2003; 
Lossie et al. 2014). Repeated Ca2+ influx due to muscu-
lar contraction activates myosin light chain kinase, and 
this enzyme phosphorylates the regulatory light chains. It 
has been shown that regulatory light chain phosphoryla-
tion results in increased Ca2+ sensitivity (Szczesna et al. 
2002), which increases the rate of force development pre-
dominantly in type II muscle fibres (Childers and McDon-
ald 2004). This might be the result of an increased number 
of force-generating cross-bridges. However, the increased 
force output by light chain phosphorylation might also 
result in elevated muscle damage, which has been shown in 
skinned fast-twitch fibres (Childers and McDonald 2004).
Two different SNPs of the myosin light chain 
kinase gene [49 (C>T) (rs2700352) and 37885 (C>A) 
(rs28497577)] have been investigated concerning exercise-
induced muscle damage (Clarkson et al. 2005b). T-allele 
carriers of the 49 (C>T) SNP have shown increased base-
line strength in comparison to CC carriers but TT homozy-
gotes revealed increased circulatory levels of the muscle 
damage biomarkers (CK and myoglobin) following eccen-
tric exercise. Furthermore, A-allele carriers of the 37885 
(C>A) SNP have revealed greater muscle strength loss and 
increased plasma CK following strenuous exercise. This 
is in line with the findings of Deuster et al. (2013), who 
showed that exertional rhabdomyolysis cases are about five 
times more likely for the A-allele of the 37885 (C>A) SNP 
of the myosin light chain kinase gene compared to carri-
ers of the C-allele. The mechanisms, however, are unclear. 
Clarkson et al. (2005b) suggested that these SNPs may 
alter regulatory light chain phosphorylation, thus leading to 
higher muscle strain and subsequently greater muscle dam-
age following strenuous exercise.
Muscle‑specific creatine kinase polymorphisms and the 
initial phase of exercise‑induced muscle damage
The creatine kinase enzyme is expressed in the cytosol 
and mitochondria of tissues with high energy consump-
tion (e.g., skeletal muscle fibres). The cytosolic enzyme is 
composed of the two subunits muscle type (M) and brain 
type (B), which provide three different combination pos-
sibilities: CK-BB (predominantly in brain), CK-MB (in 
cardiac muscle) and CK-MM (in skeletal muscle). Skeletal 
muscle-specific CK is bound to the M-line structure and to 
the sarcoplasmic reticulum of myofibrils (Wallimann et al. 
1992; Brancaccio et al. 2007). In healthy individuals, most 
serum CK consists of skeletal muscle CK (Brancaccio et al. 
2007). Creatine kinase can leak from muscle fibres into the 
circulation following the mechanical tearing of the sarco-
lemma and opening of stretch-activated channels following 
contraction-induced damage, although the exact mecha-
nism is still unclear (Allen et al. 2005).
The skeletal muscle CK-encoding gene is located at the 
19q13.2–13.3 region of the chromosome 19 (Nigro et al. 
1987). The Ncol (A>G) SNP (rs1803285) of the mus-
cle creatine kinase gene, is mapped to the 3′ untranslated 
region, which means it could affect the localization, trans-
lation efficiency and stability of the mRNA, which might 
mediate the location and function of the protein (Wilson 
et al. 1995). Interestingly, the genes for the ryanodine 
receptor 1 (Robinson et al. 2006) and myotonic dystrophy 
protein kinase (Brunner et al. 1989), which are associated 
with muscle function and specific myopathies, are mapped 
to the same area of chromosome 19. According to Deuster 
et al. (2013), Ncol GG homozygotes are present in 28.1 % 
of African Americans, in 14.2 % of Caucasians, 0 % of His-
panic and 8.3 % of Asian individuals. Investigations of the 
Ncol SNP of the muscle creatine kinase gene have revealed 
different outcomes. In the study of Deuster et al. (2013), 
GG homozygotes were reportedly 3.1 times more likely to 
experience exertional rhabdomyolysis than carriers of the 
A-allele. However, Heled et al. (2007) revealed that NcoI 
AA homozygotes had a sixfold higher risk of being a high 
responder of circulating CK to eccentric exercise than GG 
or AG genotypes. Other studies do not support a role for the 
Ncol SNP of the muscle creatine kinase gene in explain-
ing the CK variability between individuals (Miranda-Vilela 
et al. 2012; Yamin et al. 2010). However, the mechanism 
remains poorly understood and is confounded by the dif-
ferent methodological designs implemented by researchers. 
Furthermore, Heled et al. (2007) and Yamin et al. (2010) 
have only investigated CK response as a marker for muscle 
damage. Further studies with several other muscle damage 
markers such as muscle strength loss and soreness could 
provide a better physiological/systems-based understand-
ing of the influence of this NcoI SNP on exertional muscle 
damage. An additional restriction fragment length polymor-
phism, the TaqI SNP of the muscle creatine kinase gene, 
has been shown to be in strong linkage disequilibrium with 
the NcoI SNP (Miranda-Vilela et al. 2012). The TaqI 1-2 
genotype has indicated a lower risk for inflammation after a 
track event between 4 and 21 km, whereby the participants 
could choose their preferential distance. However, no fur-
ther studies have been undertaken towards understanding a 
potential role for this SNP in association with muscle dam-
age. It is possible that these SNPs change the half-life of 
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the CK enzyme and the intracellular concentration of CK 
(Heled et al. 2007). Elevated intracellular CK concentration 
might increase calpain activation, thus resulting in greater 
protein degradation.
Genetic variation and the secondary phase 
of exercise‑induced muscle damage
The secondary phase of muscle damage is a complex event 
that has been linked to inflammation (Schoenfeld 2010), 
where leucocytes infiltrate muscles with damaged fibres 
and remain there for days or even weeks (Tidball 2005). 
Although the results of published studies are inconsistent 
(Schneider and Tiidus 2007), in vitro (Kanda et al. 2013; 
Suzuki and Ford 1999) and in vivo studies (Paulsen et al. 
2010) support a role for neutrophils in muscle damage. It 
is assumed that neutrophils (Suzuki et al. 1996) migrate to 
the region of injury in the early stage of muscle damage 
(Fig. 3). Neutrophils contribute to the degradation of dam-
aged muscle tissue by producing reactive oxygen species 
(ROS), which are reported to attract macrophages to the 
area of trauma (McGinley et al. 2009; Nguyen and Tidball 
2003).
Reactive oxygen species can directly and indirectly mod-
ulate muscle damage through several mechanisms (Toumi 
et al. 2006). A potential mechanism to link oxidative stress 
with calpain-mediated proteases is via ROS decreasing 
plasma membrane Ca2+-adenosine-triphosphatase activity 
(Siems et al. 2003), which might encourage Ca2+ accumu-
lation within the cell (Powers and Jackson 2008). Although 
ROS is toxic, it may also play an important role as a sec-
ondary messenger in cell signalling and in the regulation 
of gene expression resulting in ROS-mediated adaptation to 
exercise (Schoenfeld 2012; Hornberger et al. 2003; Crane 
et al. 2013).
In contrast to neutrophils, there is strong evidence that 
macrophages and monocytes infiltrate the endomysium and 
especially the perimysium of the injured area of the mus-
cle (Hubal et al. 2008; Paulsen et al. 2010). Macrophages 
replace neutrophils within 24 h and remain present for up 
to 14 days after exercise (Malm et al. 2000). During the 
early stages of muscle damage, there is an increase of M1 
macrophages (which express CD68 surface marker but not 
CD163), supporting the removal of cellular debris by pro-
ducing cytotoxic levels of nitric oxide. This is followed by 
a shift from M1 to M2 macrophages (CD68−/CD163+), 
which promote the activation of satellite cells and the 
Fig. 3  The secondary phase of muscle damage. Leucocytes infiltrate 
the site of myotrauma (Tidball 2005). Firstly, neutrophils migrate to 
damaged muscle fibres and produce reactive oxygen species (ROS) 
to degrade cellular debris (Suzuki et al. 1996) (1). Neutrophils are 
substituted by macrophages within 24 h (Malm et al. 2000), with M1 
macrophages removing cellular debris by producing cytotoxic levels 
of nitric oxide (NO) (2). In the latter stage of muscle damage, a shift 
from M1 to M2 macrophages is associated with the activation of sat-
ellite cells and the subsequent regeneration of muscle fibres (Tidball 
2011) (3). Neutrophils and macrophages also express tumour necro-
sis factor (TNF), which activates the ubiquitin–proteasome pathway 
(Tidball and Villalta 2010) (4). This pathway regulates proteolysis by 
attaching ubiquitin polymers (Ub) to cellular debris via three different 
types of enzymes (E1–E3 ligases). As a result, these ubiquitin-marked 
proteins will be degraded by the 26S-proteasome complex (Reid 
2005)
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subsequent regeneration of muscle fibres (see “Skeletal 
muscle remodelling following exercise-induced muscle 
damage”) (Mahoney et al. 2008; Kanda et al. 2013; Tidball 
and Villalta 2010; Philippou et al. 2012; Zanou and Gailly 
2013).
Leucocyte accumulation and the following remodelling 
appear to be gradual processes regulated by the extent of 
damage (Paulsen et al. 2010, 2012). In an extreme case 
of muscle damage, remodelling may become maladaptive 
characterised by necrosis, incomplete healing, and fibrotic 
scar tissue formation (Butterfield 2010). Cytokines play 
particularly well-characterised roles in an orchestrated 
regulated fashion of the activation and modulation of the 
inflammatory response (Paulsen et al. 2012). Recent inves-
tigations revealed that some cytokines are also expressed 
by skeletal muscle, and are therefore named myokines 
(Pedersen et al. 2003). The role of cytokines in the phase 
of inflammation following exercise-induced muscle dam-
age is explained in the comprehensive review of Paulsen 
et al. (2012). Cytokines are classified as (1) pro-inflam-
matory cytokines [promoting inflammation, e.g. inter-
leukin (IL)-1α, IL-1β and tumour necrosis factor (TNF)]; 
(2) anti-inflammatory cytokines (inhibiting inflammation, 
e.g. IL-10, IL-4 and IL-13) and chemokines (abbreviated 
from chemotactic cytokines), which attract leucocytes and 
other cells to migrate from the blood to the region of injury 
[e.g., chemokine (C–C motif) ligand 2 (CCL2)] (Paulsen 
et al. 2012; Peake et al. 2005; Suzuki et al. 2002). Muscle 
cytokine expression after strenuous exercise is predomi-
nantly pro-inflammatory (Peake et al. 2005).
In addition, some cytokines such as IL-6 can act either 
as a pro- or an anti-inflammatory agent, depending on the 
environment (Pedersen and Febbraio 2008). The majority 
of cytokines are released from several cell types including 
muscle fibres, fibroblasts, neutrophils, and macrophages, 
and the expression of cytokines is determined by the mode, 
intensity and duration of exercise (Peake et al. 2015). Fur-
thermore, the action patterns of some of these cytokines 
change during the inflammatory response. These find-
ings make it difficult to identify the specific roles of each 
cytokine after exercise-induced muscle damage (Smith 
et al. 2008). However, the invading neutrophils and mac-
rophages express TNF at the early phase of inflammatory 
response (Philippou et al. 2012; Tidball and Villalta 2010; 
Warren et al. 2002a). Tumour necrosis factor is able to acti-
vate the ubiquitin–proteasome pathway, which is one of the 
main mechanisms for the cellular protein degradation in 
eukaryotic cells (Murton et al. 2008; Li et al. 2005). The 
ubiquitin–proteasome pathway regulates proteolysis by 
attaching ubiquitin polymers to damaged proteins via three 
distinct types of enzymes (known as E1–E3 ligases). Sub-
sequently, the 26S-proteasome complex degrades the ubiq-
uitin-marked protein (Reid 2005). Tumour necrosis factor 
increases the gene expression of the E3 ligases, muscle ring 
finger 1 (MuRF1) and muscle atrophy F-box (MAFbx; also 
referred to as Atrogin1) (Li et al. 2003, 2005; Murton et al. 
2008; Bodine et al. 2001). Thus, it is thought that TNF is an 
important factor in the instigation of the remodelling pro-
cess after exertional muscle damage (Murton et al. 2008).
There is evidence to suggest that muscles of older indi-
viduals exhibit higher levels of damage following strenu-
ous exercise than of younger individuals (Jiménez-Jiménez 
et al. 2008; Manfredi et al. 1991; Fielding et al. 1991; 
Roth et al. 2000). Biopsies from the vastus lateralis muscle 
revealed greater muscle damage in older men in compari-
son to younger subjects immediately after eccentric exer-
cise (Manfredi et al. 1991; Roth et al. 2000). Furthermore, 
older women demonstrated a threefold greater percentage 
reduction in strength 24 h after unaccustomed eccentric 
exercise than younger women (Roth et al. 2000). In addi-
tion, the recovery time to baseline strength was prolonged 
(up to 7 days) compared with the young sedentary sub-
jects (4 days) (Ploutz-Snyder et al. 2001). Other studies 
support the finding that the secondary phase of exercise-
induced muscle damage appears to differ between older 
and younger adults (Thalacker-Mercer et al. 2010; Jimé-
nez-Jiménez et al. 2008). On closer examination, neutro-
phil (Cannon et al. 1994) and both M1 and M2 macrophage 
(Przybyla et al. 2006; Hamada et al. 2005) recruitment is 
impaired in muscle from older individuals in the second-
ary phase of muscle damage following strenuous exer-
cise. The increase in plasma IL-6 concentration following 
eccentric exercise also tends to be blunted in older versus 
younger adults (Toft et al. 2002; Conceição et al. 2012). 
This is further supported by findings of blunted increases 
in muscle TNF and transforming growth factor-β1 (TGF-
β1) and larger increase of IL-1β messenger ribonucleic 
acid (mRNA) expression within older muscle after eccen-
tric exercise (Przybyla et al. 2006; Hamada et al. 2005). 
These findings could simply be due to the difficulty in rais-
ing levels pro-inflammatory cytokine levels over and above 
the chronically elevated levels found in older people (see 
“Skeletal muscle remodelling following exercise-induced 
muscle damage”). Alternatively, as macrophages are the 
major source of TNF and TGF-β1 within the muscle fol-
lowing exercise-induced muscle damage (Tidball 2011; 
Fadok et al. 1998), it is possible that lower macrophage 
recruitment in older individuals would lead to lower TNF 
and TGF-β1 expression and production (Hamada et al. 
2005). Unaccustomed high-intensity resistance exercise 
(sufficient to cause moderate muscle damage) has been 
shown to induce greater nuclear factor kappa-light-chain-
enhancer of activated B (NF-κB) and heat shock protein 
70 protein expression in older versus younger human 
adult muscle (Thalacker-Mercer et al. 2010). Nuclear fac-
tor kappa-light-chain-enhancer of activated B is activated 
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by pathways associated with muscle protein degradation 
(Roubenoff et al. 2003): its activation up-regulates the 
expression of muscle-specific ubiquitin ligases MAFbx and 
MuRF1 (Gumucio and Mendias 2013; Patel et al. 2014). 
Heat shock proteins mediate the correct folding of dena-
tured proteins which would explain the increased expres-
sion of heat shock protein 70 in accordance with increased 
NF-κB activation following muscle damage (Thalacker-
Mercer et al. 2010; Morton et al. 2009) (see “Genetic vari-
ation and the initial phase of exercise-induced muscle dam-
age”). Given these compelling studies, the question arises 
as to whether cytokine SNPs also play a role in muscle 
damage induction or repair or both.
Interleukin‑1 polymorphisms and the secondary phase 
of exercise‑induced muscle damage
The interleukin-1 (IL1) family of cytokine genes is located 
together on chromosome 2, and includes IL-1α (IL1A), 
IL-1β (IL1B) and IL-1 receptor antagonist (IL-1Ra; IL1RN) 
(Dennis et al. 2004). Interleukin-1α and IL-1β are agonists 
of the IL-1 receptor type I (IL-1R1) and promote inflam-
mation. In general, IL-1β acts synergistically with TNF 
and induces the expression of several other pro-inflamma-
tory genes (Dinarello 2009). Following eccentric exercise 
in humans, systemic levels of IL-1β increase marginally 
(Peake et al. 2005), but there is an increase of local IL-1β 
levels within skeletal muscle up to five days post exer-
cise (Fielding et al. 1993). In contrast, IL-1Ra acts as an 
antagonist of IL-1R1, preventing the binding of IL-1α and 
IL-1β with IL-1R1, respectively. Instead of IL-1β, IL-1Ra 
is highly concentrated in plasma following intense physi-
cal exercise (Paulsen et al. 2012). In the absence of IL-1Ra, 
the activity of IL-1 is unrestricted and leads to increased 
inflammatory response (Dinarello 2009).
Different SNPs of the IL1B gene have been investigated 
in relation to the response to exercise and exercise-induced 
muscle damage: (1) at position −511 (C>T) (rs16944) in 
the promoter region (di Giovine et al. 1992); (2) at posi-
tion +3954 (C>T) (rs1143634) in exon 5 (TaqI restriction 
site polymorphism) (Bioque et al. 1995); and (3) at position 
−3737 (C>T) (Dennis et al. 2004; Vangsted et al. 2011). 
Dennis et al. (2004) investigated the associations of selected 
IL1 SNPs with the inflammatory response following a sin-
gle bout of resistance exercise. Twenty-four sedentary Cau-
casian males were recruited based on specific clusters of 
IL1 SNPs (haplotypes) (+4845 IL1A, +3954 IL1B, −511 
IL1B, and −3737 IL1B polymorphisms). Only participants 
with the IL1B C/C (+3954) or with the T/T (−3737) geno-
type showed an increased inflammatory response (changes 
in inflammatory associated cytokines and M1 macrophages 
number) in skeletal muscle. However, the concentration of 
macrophages did not change. This leads to the assumption 
that the cytokine release by each macrophage is elevated or 
local production by the skeletal muscle itself is increased. 
Individuals with the above-mentioned genotypes, who also 
carried the C-allele of the IL1RN +2018 (T>C) SNP, dem-
onstrated a further increase of inflammatory response fol-
lowing resistance exercise.
Cauci et al. (2010) found that the IL1B +3954 (C>T) 
SNP, together with the −511 (C>T), have no influence on 
athletic phenotype, which is in accordance with the findings 
that neither plasma IL-1β nor IL1B mRNA is influenced by 
physical activity (Petersen and Pedersen 2005; Mahoney 
et al. 2008). In addition, a multi-allelic insertion polymor-
phism in intron 2 of the IL-1RN gene (rs380092) contains a 
variable number tandem repeat of an 86-bp length of DNA 
(Mansfield et al. 1994). Allele 2 (two repeats of the 86 bp 
region) of the IL1RN intron 2 variable number tandem 
repeat was significantly more frequent in athletes compared 
to non-athletes. In addition, there was a higher frequency 
distribution of the 1/2 (allele 1 with four repeats and allele 
2 with two repeats of the 86 bp region) genotype variable 
number tandem repeat IL1RN in high-grade professional 
athletes than in non-professional athletes. In contrast, the 
frequency of IL1RN allele 2 homozygotes did not differ 
between athletes and non-athletes. Unfortunately, this study 
has only distinguished between professional (high-grade), 
non-professional (medium-grade) athletes, and non-ath-
letes. Athlete status was not discriminated within the differ-
ent types of sport, which is necessary, as different mode of 
exercises require different physical traits. However, in vitro 
investigations showed that the IL1RN allele 2 has been 
associated with a lower expression of IL-1Ra (Dewberry 
et al. 2000), but increased production of the pro-inflam-
matory cytokine IL-1β (Santtila et al. 1998). Cauci et al. 
(2010) suggested that carriers of IL1RN allele-2 displayed a 
moderate increase of IL-1-dependent inflammation, which 
results in benefits to athletic performance. IL1RN allele 2 
might support the removal of cellular debris, promoting a 
faster recovery. However, IL1RN allele 2 homozygotes may 
lead to a sharp increase of inflammation, which negatively 
influences the recovery or remodelling. Further investiga-
tion is necessary to confirm these findings.
Tumour necrosis factor −308 G>A polymorphism 
and the secondary phase of exercise‑induced muscle 
damage
Tumour necrosis factor (formerly known as tumour necro-
sis factor-α) is a pro-inflammatory cytokine with short half-
life and low circulating levels (Reid and Li 2001; Pedersen 
2011) and is associated with the occurrence of metabolic 
disorders (Borst 2004). Plomgaard et al. (2005) have shown 
that TNF infusion in healthy individuals alters insulin sig-
nalling transduction and subsequently induces insulin 
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resistance in skeletal muscle. Like IL-1β, systemic TNF 
concentration does not change or is only slightly increased 
after intense exercise (Peake et al. 2015). However, local 
expression of TNF within the skeletal muscle is signifi-
cantly elevated after exercise (Peake et al. 2015). Tumour 
necrosis factor is associated with up-regulation of catabolic 
pathways and suppression of protein synthesis in skeletal 
muscle (Ling et al. 1997), mediated by NF-κB, which 
stimulates the ubiquitin–proteasome pathway (Reid and Li 
2001). This is in line with Tiainen et al. (2012), who have 
shown that high plasma levels of TNF are associated with 
reduced physical performance in men. Furthermore, intra-
venous infusion of TNF in rats led to a significant drop in 
systemic IGF-I and IGF-binding proteins 3 levels, suggest-
ing a negative influence of TNF on the IGF system (Llo-
vera et al. 1998).
The minor A-allele of the rare TNF −308 (rs1800629) 
SNP is associated with increased plasma TNF concentra-
tion (Karimi et al. 2009) and with impaired improvement 
of physical performance in older women following physi-
cal activity (Pereira et al. 2013). Presumably, the A-allele is 
a stronger activator of TNF transcription than the G-allele 
(Wilson et al. 1997). To the best of our knowledge, only 
one study has investigated an association between the 
TNF −308 (G>A) SNP and its association with exercise-
induced muscle damage. Interestingly, carriers of the 
A-allele showed a non-significant (P = 0.06) blunting of 
elevated plasma CK following eccentric exercise (Yamin 
2009; Yamin et al. 2008). However, no AA homozygotes 
were included in this investigation. The TNF −308 A-allele 
was associated with higher plasma TNF concentration 
and impaired improvements in physical fitness follow-
ing chronic exercise in older populations, while in young, 
healthy individuals, A-allele carriers demonstrated blunted 
CK activity in the blood after eccentric exercise. However, 
CK activity was measured at the peak activity 96 h post-
exercise in Yamin et al. (2008). The blunted CK activ-
ity of TNF −308 A-allele carriers in the study by Yamin 
et al. (2008) might not be attributed to the muscle damage 
itself but may be caused by attenuated remodelling, such 
as myoblast fusion which is accompanied by CK activ-
ity (Zalin 1972). Due to the fact that membrane damage 
might be repaired in a short time (Bansal et al. 2003), other 
mechanisms should be considered for the prolonged leak-
age of CK. Elevated TNF attenuates myoblast fusion and 
differentiation which might impair the regeneration of the 
muscle (Stewart et al. 2004). Subsequently, carriers of the 
TNF −308 A-allele might have a higher susceptibility to 
muscle atrophy and sarcopenia due to the impaired ability 
of muscle remodelling. However, Lappalainen (2009) has 
indicated some technical limitations of the assay which 
might have influenced the data interpretation of Yamin 
et al. (2008). Further studies are needed, which investigate 
a potential association between the TNF −308 SNP and 
other muscle damage markers.
Interleukin‑6 −174 G>C polymorphism and the 
secondary phase of exercise‑induced muscle damage
Interleukin-6 (IL-6) modulates the release of differ-
ent cytokines, such as of TNF and IL-1Ra (Steensberg 
et al. 2003; Starkie et al. 2003). The human IL6 gene is 
mapped to chromosome 7p21–24 with a 303 bp upstream 
promoter (Fishman et al. 1998). Interleukin-6 plasma 
concentration is affected by exercise duration and inten-
sity (Fischer et al. 2004), and the amount of muscle 
mass involved (Ostrowski et al. 2000), particularly dur-
ing weight-bearing exercise (Catoire and Kersten 2015). 
Eccentric exercise induces a delayed peak and a slower 
decrease of plasma IL-6 after exercise in comparison to 
other modes of exercise, such as running (Fischer 2006; 
Pedersen and Fischer 2007). According to McKay et al. 
(2009), IL-6 may play a role as an important signalling 
molecule associated with satellite cell proliferation after 
strenuous exercise. Furthermore, damaged extracellular 
matrix might have an effect on IL-6 expression, as IL-6 
is involved in collagen synthesis (Andersen et al. 2011). 
These findings suggest that the different circulating IL-6 
timescale of prolonged but non-damaging exercise and 
of eccentric exercise occurs due to a different source 
and function of IL-6 expression. Whilst muscle fibres, 
peritendinous connective tissue (Langberg et al. 2002) 
and adipose tissue (Holmes et al. 2004) all express and 
release IL-6 into the circulation without activating pro-
inflammatory pathways (Pedersen 2011), eccentric exer-
cise might induce more local IL-6 expression within the 
skeletal muscle with pro-inflammatory properties (Nie-
man et al. 1998, 2000). The delayed peak of plasma 
IL-6 concentration after strenuous eccentric exercise 
might occur due to release into the circulation follow-
ing the mechanical tearing of the sarcolemma and open-
ing of stretch-activated channels due to exertional muscle 
damage.
A functional −174 G>C SNP (rs1800795) has been 
detected in the promoter region of the IL6 gene. The fre-
quency distribution of the G-allele ranges between 45 and 
100 % in the worldwide population (Borinskaya et al. 
2013) and it is associated with an increased plasma IL-6 
response in healthy people (Bennermo et al. 2004; Fishman 
et al. 1998; Pereira et al. 2011). The −174 G-allele might 
affect the glucocorticoid receptor and elevate the transcrip-
tional activation due to its close positioning with the recep-
tor (Yamin et al. 2008; Rein et al. 1995). This IL6 SNP 
shows a somewhat ambiguous picture: according to Ruiz 
et al. (2010), both GG and GC genotypes are more frequent 
in elite power athletes compared to endurance athletes and 
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to non-athletes. There was no difference between endur-
ance athletes and the control group, which is in the line 
with the findings of Yamin et al. (2008). In young individu-
als, C-allele carriers of the IL6 SNP presented higher CK 
values following eccentric exercise compared with GG 
homozygotes (Yamin et al. 2008; Yamin 2009). In power-
orientated sports, which are associated with muscle dam-
age during training or competition, GG homozygotes might 
have benefits with faster recovery and elevated satellite 
cell proliferation in the long term. However, Deuster et al. 
(2013), who did not observe any association between this 
IL6 SNP and exertional rhabdomyolysis, challenge this 
conclusion.
Ageing-related declines in physical function are asso-
ciated with chronically elevated systemic IL-6 concentra-
tion (Ershler and Keller 2000; da Cunha Nascimento et al. 
2015). However, Walston et al. (2005) could not confirm 
any association between IL6 genotypes and serum IL-6 in 
older women. Furthermore, in the study of Funghetto et al. 
(2013), in older obese women, plasma CK integral (area 
under the curve of CK between the different time points) 
values were lower and IL-6 integral values were higher for 
carriers of the C-allele after eccentric exercise. However, 
there was only a moderate increase in plasma CK con-
centration and no change in IL-6 concentration, probably 
resulting from the relatively low intensity of the eccentric 
exercise protocol used. Of note, the interaction between 
the −174 G>C SNP and obesity seems to be a complex 
one (Joffe et al. 2013). Linkage disequilibrium of this 
−174 G>C SNP with several other SNPs on the IL6 gene 
cannot be excluded (Qi et al. 2007). In diseased, obese and 
older populations with chronically elevated circulating 
IL-6, an increased IL-6 response might be harmful after 
eccentric exercise (Funghetto et al. 2013; Bennermo et al. 
2004).
In summary, the pattern of circulatory IL-6 and CK lev-
els in association with the IL6 −174 G>C SNP appears 
to be diametrically opposed. It might be that an elevated 
IL-6 response and lower CK levels associated with the 
G-allele are beneficial due to increased IL-6 production of 
macrophages (Patel et al. 2010) and satellite cell prolifera-
tion (McKay et al. 2009) in a healthy population follow-
ing eccentric exercise (Yamin et al. 2008). However, the 
G-allele might have a negative effect in those presenting 
with chronic low-grade systemic inflammation. Without 
knowing the actual source of IL-6 expression and its subse-
quent pro- or anti-inflammatory effect, cumulative plasma 
IL-6 concentration is probably an inaccurate biomarker of 
muscle damage (Pedersen and Febbraio 2008). The influ-
ence of the IL6 −174 G>C SNP is not fully clear and 
needs further investigation, particularly in conjunction with 
both local and circulatory measures of IL-6 expression/
concentration.
Chemokine ligand 2 and chemokine receptor 
type 2 polymorphisms and the secondary phase 
of exercise‑induced muscle damage
Like interleukin-6, the chemokine (C–C motif) ligand-2 
(CCL2), also known as monocyte chemoattractant pro-
tein 1 (MCP1), can be classified as an exercise factor, as 
it mediates systemic changes induced by chronic exercise 
training (Catoire and Kersten 2015). Monocyte chem-
oattractant protein 1 receptor (CCR2) is one of the major 
receptors, which binds CCL2, beside CCL7 and CCL13 
(Harmon et al. 2010). CCL2 is mainly expressed within 
the interstitial space between myofibres following muscle 
damaging exercise, and is co-localised with macrophages 
and satellite cells in the muscle (Hubal et al. 2008). Con-
centric exercise does not influence local CCL2 expression 
(Hubal et al. 2008). However, in line with the findings of 
Warren et al. (2005), that Ccr2-knockout mice have shown 
impaired regeneration, inflammation, and fibrotic response 
following freeze injury, a strong interaction between 
CCL2/CCR2 and the immune response after muscle dam-
age is suggested (Hubal et al. 2008; Yahiaoui et al. 2008). 
Interestingly, whilst local CCL2 mRNA expression fur-
ther increased after a second bout of eccentric exercise in 
comparison to the first bout (Hubal et al. 2008), systemic 
response of CCL2 decreased after repeated downhill run-
ning (Smith et al. 2007).
Hubal et al. (2010) investigated several CCL2/CCR2 
SNPs in association with exercise-induced muscle damage 
in the elbow flexor muscles. Following strenuous exercise, 
the T-allele of the CCL2 rs3917878 (C>T) SNP was associ-
ated with a delayed recovery of maximum strength in men 
and a higher CK response in women (Hubal et al. 2010). 
C-allele carriers of the CCR2 (rs3918358) SNP showed a 
delayed recovery of strength in females, and the C-allele 
of the CCR2 (rs1799865) SNP increased soreness in both 
genders (Hubal et al. 2010). The significant differences 
between the alleles of these three SNPs occurred 4–10 days 
following exertional muscle damage, confirming the action 
pattern of CCL2/CCR2 in muscle repair/regeneration. 
Furthermore, the GG genotype of the CCL2 gene variant 
(rs2857656), for which significant differences were found 
in pre-exercise maximum strength compared to the major 
C-allele (Harmon et al. 2010), was associated with the 
magnitude of muscle injury in professional soccer players 
(Pruna et al. 2013). According to Hubal et al. (2010), there 
were moderate associations between CCL2/CCR2 geno-
types and baseline CCL2 activity (as a product of CCL2 
expression and the availability of CCR2). Higher CCL2 
activity might be an advantage in the recovery period fol-
lowing muscle damage in healthy individuals due to its 
ability to serve as a chemoattractant to macrophages and its 
possible activation of satellite cell proliferation (Yahiaoui 
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et al. 2008). However, further investigation is needed to 
identify the potential molecular mechanisms underpinning 
the influence of each of these SNPs in changing CCL2 
activity in response to muscle damaging exercise in elderly 
and obese people, in whom chronic systemic inflammation 
is already an issue.
Osteopontin −66 T>G polymorphism and the 
secondary phase of exercise‑induced muscle damage
The extracellular matrix protein and pro-inflammatory 
cytokine osteopontin (also known as secreted phosphopro-
tein 1) is expressed in numerous cell types including skele-
tal muscle (Kahles et al. 2014; Zanotti et al. 2011; Giachelli 
et al. 1998). Whereas the earliest studies suggested that it 
had a central role in bone remodelling (Rodan 1995), sub-
sequent studies suggest that osteopontin has also a role as 
a chemoattractant for macrophages (Hirata et al. 2003), 
and possibly neutrophils (Yang et al. 2014). Osteopontin is 
virtually undetectable in resting skeletal muscle but, after 
induced muscle damage in mice, osteopontin expression is 
elevated 100-times compared to baseline transcription lev-
els (Hoffman et al. 2013; Hirata et al. 2003).
A common SNP in the transcriptional promoter of the 
osteopontin gene (−66 T>G, rs28357094), which over-
laps a specificity protein-1 transcription factor-binding 
site, results in different phenotypic characteristics (Barfield 
et al. 2014). The minor G-allele is associated with an 80 % 
reduction in osteopontin gene expression in vitro (Gia-
copelli et al. 2004; Barfield et al. 2014) and with a 17 % 
increase in baseline upper arm muscle volume in women 
(Hoffman et al. 2013). Surprisingly, this increased muscle 
volume did not influence muscle strength (Hoffman et al. 
2013). After exercise-induced muscle damage, women car-
rying the G-allele revealed significantly elevated muscle 
swelling, increased loss of muscle strength (Barfield et al. 
2014) and CK values were elevated in two women with the 
rare GG genotype (Hoffman et al. 2013). In contrast, the 
G-allele was linked with less grip strength and with more 
rapid progression in patients with Duchenne muscular 
dystrophy (Pegoraro et al. 2011). Further investigations of 
Barfield et al. (2014) revealed several enhancer sequences 
on the osteopontin gene promoter for multiple steroid hor-
mone-binding sites (i.e. oestrogen receptor, glucocorticoid 
receptor, vitamin D receptor and a potential NF-κB bind-
ing site). Oestrogen hormone treatment of modified human 
myoblasts with the allele-specific osteopontin promoters 
has shown that the human myoblasts with the transfected 
G-allele promoter revealed a threefold increase in osteo-
pontin gene expression, whereas the T-allele construct was 
unaffected by oestrogen treatment. From this, we can infer 
that there may be an allele-specific interaction between 
the oestrogen enhancer and the more proximal specificity 
protein-1 transcription factor site leading to a hypothetical 
model for sexual dimorphism (Barfield et al. 2014). Thus, 
women with the G-allele seem to be more susceptible to 
muscle damage. Likewise, a similar allele-specific inter-
action between the NF-κB or glucocorticoid binding site 
and the specificity protein-1 transcription factor site might 
explain the association between the G-allele and Duch-
enne muscular dystrophy. Barfield et al. (2014) suggest that 
chronic inflammation might lead to an augmentation of the 
pro-inflammatory response, which accelerates the progress 
of the disease. However, the study of Barfield et al. (2014) 
has several limitations. TT genotype has shown a similar 
loss of force over time in both the exercised and non-exer-
cised arm following exertional muscle damage. In addition, 
due to the low number of volunteers (n = 6) who com-
pleted the eccentric exercise intervention, further investiga-
tions are needed to replicate and verify these findings.
Skeletal muscle remodelling 
following exercise‑induced muscle damage
Skeletal muscle regeneration is a complex process that is 
mediated by satellite cells, and in which several factors are 
activated to regulate muscle remodelling (Kurosaka and 
Machida 2012). Satellite cells are mononucleated muscle 
stem cells and are located on the outer surface of the mus-
cle fibre, between the basal lamina and sarcolemma (Hawke 
and Garry 2001). Usually, satellite cells remain quiescent 
but are activated following damage (Fig. 4) (Chambers and 
McDermott 1996; Grobler et al. 2004). They proliferate 
24–48 h later and then do one of three things: (1) return 
to quiescence and restore the population of satellite cells; 
(2) migrate to the site of injury and support the repair pro-
cess by increasing the nuclei-to-cytoplasm ratio; (3) fuse 
with other myogenic cells to form myotubes, thus generat-
ing new fibres to replace damaged myofibres (Hawke and 
Garry 2001; Grobler et al. 2004; Tidball and Villalta 2010; 
Sharples and Stewart 2011).
Macrophages are essential, not only for removing tis-
sue debris, but also in the activation of satellite cells. M1 
macrophages provoke myoblast proliferation (Arnold et al. 
2007; Cantini et al. 2002) and, together with neutrophils, 
they attract satellite cells to the site of injury by releasing 
TNF (Torrente et al. 2003). M2 macrophages stimulate 
the differentiation of satellite cells into mature myofibres 
(Arnold et al. 2007), and in vitro studies indicate that mac-
rophages support differentiation through ultimate increases 
in myogenin expression (Cantini et al. 2002). Activated 
satellite cells initially up-regulate two different myogenic 
regulatory factors, MyoD and myogenic factor-5 (Smith 
et al. 1994). In the period of proliferation, the satellite 
cells express paired box protein 7 (Pax7) and MyoD but 
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those that return to quiescence to maintain the satellite cell 
pool only express Pax7 (Tedesco et al. 2010; Al-Shanti 
and Stewart 2009). However, subsequent down-regulation 
of Pax7/3 induces cell differentiation. The satellite cells 
exit the cell cycle and enter the early differentiation stage 
where myogenic factor 6 (herculin) and myogenin are up-
regulated (Zammit 2008; Wahl et al. 2008; Le Grand and 
Rudnicki 2007). Myoblasts differentiate into myocytes 
and then eventually fuse and form multinucleated myofi-
bres (Le Grand and Rudnicki 2007). Recent investigations 
revealed that MyoD and myogenin induce myomaker gene 
transcription (Millay et al. 2013, 2014). The absence of 
myomaker, which is expressed on the cell surface of myo-
blasts, leads to inhibition of myoblast fusion in mice (Mil-
lay et al. 2013). However, more information is required to 
explain the roles of myomaker in muscle regeneration and 
recovery following muscle damaging exercise.
The extracellular matrix provides structural and bio-
chemical support to contractile tissue and it is associated 
with the inflammatory response and satellite cell activa-
tion (Hyldahl and Hubal 2014; Kjær 2004). Activated 
satellite cells migrate to the site of injury along the basal 
lamina (Hughes and Blau 1990), a process that is facili-
tated by the basal lamina components (i.e. collagen IV, 
laminin-2 and nidogens) (Goetsch and Niesler 2011). 
Components of the extracellular matrix (collagen I and 
III, fibronectin and other extracellular matrix molecules) 
provide a temporary scaffold to support the migration of 
the activated progenitor cells (Goetsch et al. 2013). Dif-
ferent chemotactic gradients, including a large num-
ber of chemokines, also support the migration from the 
niche towards the site of myotrauma, and some of these 
chemokines are released from the extracellular matrix 
itself (Griffin et al. 2010; Goetsch et al. 2013). Further-
more, there is evidence that synthesis of type I, III and 
probably IV collagen within the endomysium and the 
perimysium increase after contraction-induced damage 
(Mackey et al. 2004; Koskinen et al. 2001).
Fig. 4  The cycle of skeletal muscle fibre regeneration following 
exercise-induced muscle damage. This cycle is mediated by satellite 
cells, which are activated following stressful physiological conditions 
such as exercise-induced muscle damage (Grobler et al. 2004). Acti-
vated satellite cells initially up-regulate two different myogenic regu-
latory factors, MyoD and myogenic factor-5 and, during the prolifera-
tion, paired box protein 7 (Pax7). If satellite cells return to quiescence 
and restore the population of satellite cells, MyoD will be down-reg-
ulated (i). However, subsequent cell differentiation is accompanied 
with down-regulation of Pax7/3. During this early differentiation 
stage, herculin and myogenin are up-regulated. Myoblasts differen-
tiate into myocytes and then eventually migrate to the site of injury 
and support the repair process by increasing the nuclei-to-cytoplasm 
ratio (ii). Different chemotactic gradients, including a large number 
of chemokines, support the migration to the region of injury. A recent 
investigation in mice revealed that the absence of myomaker, which 
is expressed on the cell surface of myoblasts, leads to inhibition of 
myoblast fusion (Millay et al. 2013). Alternatively, the myocytes fuse 
with other myogenic cells to form myotubes, thus generating new 
fibres to replace damaged myofibres (iii). Figure adapted from Tidball 
(2011) and Al-Shanti and Stewart (2009)
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Chronic low-grade systemic inflammation (i.e. elevated 
levels of circulating pro-inflammatory cytokines), is a com-
mon observation in older people (Conceição et al. 2012; 
Franceschi et al. 2007). In this context, basal circulating 
cytokines (e.g. TNF and IL-6) and myostatin were found 
to correlate inversely with grip strength of older men (Patel 
et al. 2014). Although the mechanism for this inverse rela-
tionship is still unclear, it is possible that pro-inflammatory 
cytokines interfere with satellite cell differentiation, accel-
erate muscle protein degradation and inhibit muscle protein 
synthesis, leading to reduced muscle mass and strength. 
This would also result in slower repair and reduced adapta-
tion of older skeletal muscle to resistance exercise (Peake 
et al. 2010). Indeed, Dreyer et al. (2006) have counted 
the numbers of satellite cells per muscle fibre 24 h after a 
single bout of maximal eccentric exercise. Although both 
young and older men demonstrated an increase in satellite 
cell numbers, the response was significantly blunted in the 
older population. However, it is still a matter of debate, if 
the number of satellite cells changes during the ageing pro-
cess, and whether this is the main cause for what has been 
coined anabolic resistance in the elderly.
Gene polymorphisms of the insulin‑like growth factor 
family and the remodelling fsignificant gain in muscle 
cross‑sectional areaollowing exercise‑induced muscle 
damage
The complex process of remodelling is influenced by growth 
factors including insulin-like growth factor-I (IGF-I) and 
IGF-II (Duan et al. 2010). In addition to IGF-I (IGF1) and 
IGF-II (IGF2), the IGF system consists of several IGF-bind-
ing proteins, the insulin receptor, and cell surface receptors 
such as the IGF-I receptor and the IGF-II receptor (Wang 
et al. 2015). This system promotes satellite cell differentia-
tion and proliferation (O’Dell and Day 1998; Florini et al. 
1996; Stewart and Rotwein 1996a, b; Stewart et al. 1996) and 
is thought to play an important role during exercise-induced 
muscle hypertrophy (Sharples and Stewart 2011; Matheny 
et al. 2009). For example, transgenic mice overexpressing 
Igf-I in skeletal muscle revealed a significant gain in muscle 
cross-sectional area in comparison with wild type mice fol-
lowing chronic muscle overload (Paul and Rosenthal 2002). 
Inactivation of the type 1 Igf receptor inhibits the presence of 
newly formed nuclei in exercised transgenic mice (Fernán-
dez et al. 2002; Jiao et al. 2013; Wilson et al. 2003), while 
maintaining local IGF-I concentration is considered crucial 
for maintaining muscle mass and strength with advancing 
age (Barton-Davis et al. 1998; Musarò et al. 2001).
Besides their role in hypertrophy, IGFs are crucial in 
muscle regeneration following exercise or muscle injury 
(Jiao et al. 2013; Mackey et al. 2011). Insulin-like growth 
factor-I acts mainly in an autocrine and paracrine manner 
to stimulate satellite cells to proliferate and differentiate. 
Different isoforms [IGF-IEa, IGF-IEb (in rat) and IGF-IEc 
(in human)] of IGF-I are associated with muscle damage 
and regeneration. Insulin-like growth factor-IEb and IGF-
IEc are also known as mechano-growth factor, because the 
mRNA is expressed in response to overload or damage in 
skeletal muscle. The expression of mechano-growth fac-
tor is enhanced shortly after muscle damage, which sub-
sequently promotes satellite cell activation (Hill and Gold-
spink 2003). Afterwards, increased expression of IGF-IEa 
elevates myoblast fusion (Yang and Goldspink 2002; Jiao 
et al. 2013). Mechano-growth factor also promotes the 
activity of cytoplasmic superoxide dismutase, thus pro-
tecting against ROS during the inflammatory response to 
muscle damaging exercise (Dobrowolny et al. 2005). Both 
IGF-I and IGF-II mRNA increase during myoblast dif-
ferentiation, but presumably autocrine IGF-II is the pre-
dominant myogenic factor during differentiation due to its 
enhanced expression, whilst IGF-II is probably elevated 
to suppress IGF-I gene expression via the mTOR pathway 
(Jiao et al. 2013; Wilson et al. 2003). Marsh et al. (1997) 
have also shown an age-dependent decline of IGF2 gene 
expression following muscle damage in rats.
As far as we are aware, only Devaney et al. (2007) have 
tested the association between IGF SNPs and exercise-
induced muscle damage. Several different SNPs were 
investigated, as the IGF2 gene region consists of three 
genes: IGF2, IGF2 anti sense (IGF2AS), and the insulin 
gene (Lee et al. 2005). The following SNPs: IGF2 (17200 
G>A, rs680); IGF2 (13790 C>G, rs3213221); IGF2AS 
(1364 A>C, rs4244808); IGF2AS (11711 G>T, rs7924316), 
were significantly associated with exercise-induced muscle 
damage. Besides an association between the IGF2 17200 
(G>A, rs680) and IGF2 13790 (C>G, rs3213221) SNPs 
and soreness (after 3 and 4 days), and CK activity in the 
blood (both after 7 days) following muscle damaging exer-
cise, every IGF2 SNP investigated was associated with 
strenuous exercise-induced muscle strength loss in men. 
Only the IGF2AS 1364 (A>C, rs4244808) SNP was associ-
ated with strength loss immediately after exertional muscle 
damage in both men and women. In contrast, carriers of the 
insulin gene 1045 (C>G, rs3842748) SNP have shown an 
increased CK activity 10 days after exercise-induced mus-
cle damage only in women.
Varying IGF-I or IGF-II levels potentially caused by 
these SNPs could modulate satellite cell activation and dif-
ferentiation. For instance, the IGF1 cytosine adenine-repeat 
SNP located in the promoter region of the IGF-I gene is 
believed to change circulating IGF-I levels but the evi-
dence is equivocal (Vaessen et al. 2001; Rosen et al. 1998; 
DeLellis et al. 2003; Allen et al. 2002). While Vaessen et al. 
(2001) suggest IGF-I levels are increased by these SNPs, 
other investigations found a decrease (Rosen et al. 1998) 
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or no difference in IGF-I levels (Allen et al. 2002; DeLellis 
et al. 2003).
It is remarkable that several SNPs of IGF2 were associ-
ated with a loss of muscle strength directly after exertional 
muscle damage, in particular in men. It seems there must 
be another process, whereby the IGF2 gene is involved in 
the response to muscle damaging exercise separately from 
regeneration and differentiation. Here, we would like to 
highlight a new hypothesis. Insulin-like growth factor I also 
plays an important role in the regulation of protein synthe-
sis, including collagen and myofibrillar protein. Local IGF-
IEa and IGF-IEc mRNA expression is positively correlated 
with musculotendinous mRNA expression of COL1A1/3A1 
(Boesen et al. 2013; Doessing et al. 2010) and may sub-
sequently increase collagen synthesis in the extracellular 
matrix (Hansen et al. 2013). Lower circulating IGF-I lev-
els induced by IGF SNPs may negatively influence the sta-
bility of the extracellular matrix. Therefore, a subsequent 
loss in the lateral transmission of force between adjacent 
muscle fibres might occur, which could be the source of the 
decrease in maximum strength observed immediately after 
strenuous exercise. Although, to the best of our knowledge, 
no direct effect of IGF-II concentration on human extracel-
lular matrix protein synthesis is known, Keller et al. (1999) 
has shown that local Igf-II expression increases after injury 
in murine muscle. It is therefore possible that IGF-II is 
linked with exercise-induced muscle damage in human 
muscle, and possibly with extracellular matrix integrity. A 
direct or indirect influence of IGF-II level on extracellular 
matrix integrity would, at least in part, explain the signifi-
cant strength loss after muscle damaging exercise and the 
association of the IGF2 13790 (C>G, rs3213221) SNP with 
the degree of injury in soccer players (Pruna et al. 2013).
Additional gene polymorphisms associated 
with exercise‑induced muscle damage
The following gene polymorphisms have been associated 
with exercise-induced muscle damage. However, further 
investigation is necessary to attribute these polymorphisms 
to a specific phase of exercise-induced muscle damage.
Angiotensin‑I converting enzyme insertion/deletion 
polymorphism
Angiotensin-I converting enzyme (ACE) has a key role in 
the interaction between the kallikrein-kinin and the renin-
angiotensin systems (Schmaier 2003). Angiotensinogen, 
which is a precursor protein in the renin-angiotensin sys-
tem, is produced constitutively and released into the circu-
lation mainly by the liver (Deschepper 1994), and can be 
cleaved by the protease renin, resulting in the decapeptide 
angiotensin-I. The dipeptidase ACE converts angiotensin-
I to the octapeptide hormone angiotensin-II, which acts as 
a vasoconstrictor (Munzenmaier and Greene 1996), and 
induces skeletal muscle hypertrophy in response to mechan-
ical loading (Gordon et al. 2001). Angiotensin-I converting 
enzyme also cleaves the vasodilator bradykinin (Dendorfer 
et al. 2001), which supports the increase of arterial blood 
pressure (Murphey et al. 2000), as well as Substance P, a 
protein from the tachykinin family that functions as a neu-
rotransmitter (released by group III and IV afferent fibres) 
(Harrison and Geppetti 2001; Inoue et al. 1998).
The ACE insertion/deletion (I/D) polymorphism 
(rs4646994) was the first gene variation to be investigated 
in the context of human physical performance-related 
traits, and is the most investigated in the renin–angio-
tensin system (Gayagay et al. 1998; Montgomery et al. 
1998). The insertion (I) allele of a 287 bp Alu sequence 
within intron 16 on chromosome 17 is linked to lower ACE 
activity in serum (Rigat et al. 1990) and in cardiac mus-
cle (Phillips et al. 1993; Danser et al. 1995), and reduced 
bradykinin degradation (Murphey et al. 2000) compared to 
carriers of the D-allele. Carriers of the I-allele are associ-
ated with greater endurance capacity (Montgomery et al. 
1998; Ma et al. 2013), whereas the D-allele is associated 
with greater muscular strength (Williams et al. 2005), and 
elite power athlete status (Costa et al. 2009; Nazarov et al. 
2001; Woods et al. 2001). However, recent investigations 
have observed that this distinction is not considered suffi-
ciently specific to detect all the phenotypic effects (Lucia 
et al. 2005; Rankinen et al. 2000; Thompson and Binder-
Macleod 2006).
The association between the ACE I/D polymorphism and 
elite athlete status might be explained by a genotype link 
with the susceptibility to exertional muscle damage and 
injury. To the best of our knowledge, only two studies have 
investigated the influence of the ACE I/D polymorphism on 
contraction-induced damage in humans (Heled et al. 2007; 
Yamin et al. 2007). Yamin et al. (2007) observed differ-
ent concentrations of circulatory CK between ACE geno-
types after eccentric exercise: II homozygotes elicited the 
highest CK response, whilst DD homozygotes elicited the 
lowest plasma CK activity after strenuous exercise. This 
suggests that the I-allele is associated with a greater sus-
ceptibility to muscle damage, and the potential mechanism 
is explained below. However, Heled et al. (2007) could not 
find any association between ACE I/D polymorphism and 
CK response. The different outcome is probably attributed 
to the moderate-intensity exercise test and higher activ-
ity level and different ethnicities of the participants in the 
study of Heled et al. (2007). It should be noted that only 
CK level was investigated in both studies, which is only 
one of several indirect biomarkers of exercise-induced 
muscle damage.
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In rabbit studies, inhibition of ACE revealed [in combi-
nation with neutral endopeptidase inhibitor] elevated mus-
cle damage in a muscle overuse model induced by electri-
cal stimulation every second day with four sessions in total 
(Song et al. 2014), which is in line with the human findings 
of Yamin et al. (2007). The muscle damage was accompa-
nied by increased tachykinin, substance P and its preferred 
receptor neurokinin-1 receptor expression, which suggests 
that the tachykinin family may play a role in the inflam-
matory processes and pain (Song et al. 2014; Dousset et al. 
2007). Substance P is widely expressed in human cells and 
tissues of the peripheral and central nervous systems but it 
is also found in extra neuronal cells and innervated tissues. 
Substance P and neurokinin-1 receptor have been associ-
ated with the inflammatory response in smooth muscle 
cells and dermal tissues but not in skeletal muscle (Renzi 
et al. 2000; Luger 2002). However, elevated substance P 
might result in improved remodelling, as demonstrated in 
the healing of a rat Achilles tendon (Bring et al. 2012; Stey-
aert et al. 2010).
In contrast, angiotensin-II is known to be involved in 
inflammatory process following muscle damage. Block-
ing of the angiotensin-II receptor type 1 improves regen-
eration of injured skeletal muscle (Bedair et al. 2008) and 
suppresses ROS production following strenuous exercise in 
mice (Sim et al. 2014). Furthermore, nerve growth factor 
up-regulation through activation of B2 bradykinin recep-
tors is strongly associated with increased pain sensitivity 
(hyperalgesia) (Murase et al. 2010; Babenko et al. 1999). 
Angiotensin-I converting enzyme D-allele carriers, which 
have a decreased bradykinin half-life, might have attenu-
ated nerve growth factor expression following exertional 
muscle damage and therefore a decreased pain sensitivity. 
Attenuated substance P and bradykinin in the inflammatory 
process may explain the high frequency of D-allele carri-
ers among elite strength/power athletes (Costa et al. 2009). 
Athletes with the D-allele might feel less pain and there-
fore might be able to (1) sustain high-intensity training 
for longer, (2) reach the limits of their capacity in power/
strength related competition (3) or enable them to practise 
more often due to a decreased sensitivity to pain. In other 
sport-specific movements, such as short distance swimming 
(<200 m), it is crucial to sustain a high level of intensity 
accompanied with exercise-induced muscle burning (Costa 
et al. 2009; Woods et al. 2001).
Another possibility might be that angiotensin-II indi-
rectly mediates skeletal muscle damage by influencing 
angiogenesis in response to exercise (Vaughan et al. 2013). 
It is well known that, in a damaged muscle in the days fol-
lowing eccentric exercise, resting capillary blood flow is 
elevated and vasodilatation occurs (Rubinstein et al. 1998). 
According to Vaughan et al. (2013), the capillary density 
of skeletal muscle is lower in untrained carriers of the ACE 
I-allele compared to DD homozygotes. Lower capillary 
density might impair the migration of neutrophils and mac-
rophages as well as of the removal of cellular debris, which 
could negatively affect the extent of muscle damage and 
possibly muscle remodelling.
Mitochondrial superoxide dismutase 2 Ala16Val 
polymorphism
Strenuous exercise results in oxidative stress, which causes 
structural damage to muscle fibres and stimulates an 
inflammatory response (Gomez-Cabrera et al. 2008), as 
discussed in “Genetic variation and the secondary phase 
of exercise-induced muscle damage”. A higher intracel-
lular concentration of antioxidants within a muscle fibre 
is thought to protect against the negative impact of ROS 
(Schoenfeld 2012; Peake and Suzuki 2004). Superoxide 
dismutase is an antioxidant that protects cells and mito-
chondria from free radical damage by converting the anion 
superoxide into hydrogen peroxide (Huang et al. 2000). 
Inhibition of superoxide dismutase causes the accumula-
tion of superoxide radicals, and can lead to increased dam-
age of mitochondrial membrane and cell apoptosis (Huang 
et al. 2000). The Ala16Val (rs4880, C>T) SNP of the super-
oxide dismutase 2, mitochondrial gene (SOD2), has been 
associated with muscle damage susceptibility. The T-allele 
is associated with reduced mitochondrial superoxide dis-
mutase efficiency against oxidative stress (Shimoda-Mat-
subayashi et al. 1996). Akimoto et al. (2010) demonstrated 
that trained runners of TT genotype had an increased 
plasma CK concentration after racing 4–21 km. This is in 
line with Ahmetov et al. (2014), who revealed that TT car-
riers of the mitochondrial superoxide dismutase gene were 
under-represented in power and strength athletes compared 
to controls and athletes of low-intensity sports, such as 
curling players and shooters. Interestingly, in the study of 
Ben-Zaken et al. (2013), the frequency of the C-allele was 
significantly higher in both endurance and power athletes 
in comparison to the control group. At first glance, these 
studies seem to be inconsistent with one another. On closer 
inspection, both studies recruited different types of partic-
ipants. In the study of Ahmetov et al. (2014) participants 
covered a wide range of different sports, whereas in Ben-
Zaken et al. (2013), only track and field related athletes 
participated: 100 and 200 m sprinters and long jumpers 
(power athletes); 5000 m and marathon runners (endurance 
athletes). These track and field athletes perform sport-spe-
cific movements that is accompanied by stress to the mus-
culoskeletal system through repeated eccentric muscle con-
tractions performed over long periods of time, which leads 
to muscle damage. The inflammation accompanying this 
damage potentially produces more oxidative stress than the 
endurance sports (e.g. swimming) in the study by Ahmetov 
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et al. (2014). Therefore, the T-allele might impair the pro-
tection against oxidative stress due to the lower efficiency 
of the mitochondrial superoxide dismutase gene. This may 
indicate that there is a relationship between this SNP and 
level of athletic performance in sports with a potential risk 
of muscle damage. Unfortunately, no study has tested the 
effect of the mitochondrial superoxide dismutase SNP on 
exercise-induced muscle damage over the course of time. 
This could provide insight into the influence of the mito-
chondrial superoxide dismutase C>T SNP on the secondary 
phase of muscle damage and the subsequent remodelling.
Solute carrier family 30 member eight C>T 
polymorphism
Ageing is often accompanied by insulin resistance due to 
reduced habitual physical activity, a reduction in muscle 
mass and an increase in adipose tissue (Dela and Kjaer 
2006; Dela et al. 1996). Type 2 diabetes mellitus is associ-
ated with disturbed zinc homeostasis and down-regulation 
of the solute carrier family 30 (zinc transporter) mem-
ber eight, the product of the SLC30A8 gene (Somboon-
wong et al. 2015). Solute carrier family 30 member eight 
is mainly expressed in pancreatic islet beta cells and it 
transports zinc from the cytoplasm into intracellular vesi-
cles, which is crucial for insulin crystallisation, storage, 
and secretion (Cheng et al. 2015; Lemaire et al. 2009; 
Chimienti et al. 2006). The C-allele of the nonsynonymous 
SLC30A8 (C>T) SNP (rs13266634) is strongly associated 
with type 2 diabetes mellitus risk, in particular in Euro-
pean and Asian populations but not in African populations 
(Cheng et al. 2015). This SLC30A8 R325W SNP is associ-
ated with, amongst others, decreased fasting systemic insu-
lin and attenuated insulin secretion in response to glucose 
intake (Staiger et al. 2007; Sprouse et al. 2014; Kirchhoff 
et al. 2008).
In recent years, there has been an increase in the number 
of investigations regarding insulin resistance and muscle 
function in people without type 2 diabetes mellitus. Insu-
lin resistance is not only associated with lower force and 
muscle mass in young and old individuals with diabetes 
(Andreassen et al. 2009; Andersen et al. 2004), but also in 
both young (Gysel et al. 2014) and older (Barzilay et al. 
2009) healthy people. Insulin signalling increases blood 
flow and protein synthesis at rest, and suppresses the break-
down of proteins after resistance exercise, thus improving 
net muscle protein balance in particular with amino acid 
delivery and availability (Biolo et al. 1999; Fujita et al. 
2006). Furthermore, exercise-induced muscle damage has 
been associated with impaired glycogen synthesis (Cos-
till et al. 1990) and reduced glucose uptake (Nielsen et al. 
2015; Asp et al. 1996), probably due to muscle damage 
reducing muscle insulin sensitivity (Kirwan et al. 1991). 
This could be due to increased TNF expression attenuating 
insulin signalling transduction, subsequently inducing insu-
lin resistance in skeletal muscle (Plomgaard et al. 2005) 
and suppressing the activation of glucose transporter type 4 
in muscle fibres (Asp et al. 1995).
Sprouse et al. (2014) reported that the TT genotype of 
the SLC30A8 SNP was associated with lower biomarkers of 
muscle damage (reduced soreness, strength loss and plasma 
CK and myoglobin levels) following eccentric contrac-
tions of the elbow flexor muscles in men. By increasing the 
catabolic pathway, lower insulin levels can lead to a nega-
tive net protein balance (Woolfson et al. 1979; Sacheck 
et al. 2007). Therefore, carriers of the SLC30A8 C-allele 
might need longer times to recover from strenuous exer-
cise. Further studies should investigate if SLC30A8 geno-
type-dependent insulin production is associated with the 
acute and chronic adaptations to resistance exercise, with 
regard to muscle protein synthesis and muscle hypertrophy, 
respectively.
Discussion
Exercise-induced muscle damage provokes a prolonged 
loss of muscle strength, and both elevated soreness and 
circulating muscle-specific protein levels. The grade and 
actual time-course of strength loss, soreness and of the 
inflammation response after exercise is variable. Several 
factors that are well documented can influence the response 
to muscle damaging exercise, such as exercise mode, inten-
sity or duration (Smith et al. 1989), micro nutrition (Owens 
et al. 2014; Bhat and Ismail 2015; Barker et al. 2013) 
and muscle (group) intervention (Clarkson and Hubal 
2002). Nevertheless, within-study variability is often seen 
in response to strenuous exercise (Nosaka and Clarkson 
1996).
Several studies have reported differences in SNP-spe-
cific gene activity resulting in different expression of the 
coding proteins, which may influence the susceptibly to 
exercise-induced muscle damage (Seto et al. 2011). Indi-
viduals, who are high responders to exercise-induced 
muscle damage (i.e. demonstrate a greater loss of muscle 
strength and higher circulating levels of CK or myoglobin) 
might have a higher predisposition to injury (Kibler et al. 
1992; Clansey et al. 2012). This is in line with the observa-
tion that history of one type of muscle injury increases the 
risk of developing other types of muscle injuries (Orchard 
2001; Freckleton and Pizzari 2013). The same principle 
may apply to high responders to exercise-induced muscle 
damage in a squad of athletes performing the same exer-
cise training together. High responders, who might need a 
longer recovery time after a strength training intervention 
in comparison to others in the same squad, might have a 
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higher potential for musculotendinous injuries due to over-
training. Both presumptions may result in an increased 
dropout rate of athletes with specific genotype profiles due 
to higher rates of (overtraining) injury extending over sev-
eral years (Kibler et al. 1992). It would be interesting to 
investigate if a high responder to exercise-induced mus-
cle damage is a low/high responder to chronic resistance 
training.
Eccentric resistance exercise training is a potent method 
of inducing muscle hypertrophy (Seynnes et al. 2007; 
Norrbrand et al. 2008), and may therefore be prescribed 
to older people to counter sarcopenia (Reeves et al. 2004; 
Morse et al. 2007). However, the increased susceptibility to 
muscle damage following eccentric exercise in older peo-
ple (Ploutz-Snyder et al. 2001) might lead to an increased 
risk of over-use injuries and impaired recovery from injury 
(Brooks and Faulkner 1990; McArdle et al. 2004). Fur-
thermore, if certain older individuals are genetically pre-
disposed to experience relatively more exercise-induced 
muscle damage than age-matched individuals with a pro-
tective genetic profile, these people are at an even greater 
risk of injury. Thus, a different form of exercise may be 
more appropriate for these individuals. The identification 
of both young and older high-risk individuals would, there-
fore, allow more personalised exercise prescriptions to help 
reduce the risk of injuries and maintain/improve quality of 
life.
Association studies can potentially reveal new mecha-
nisms of genes. For instance, several IGF2 SNPs have been 
associated with strength loss immediately after muscle 
damaging exercise, which cannot exclusively be explained 
by satellite cell differentiation (Devaney et al. 2007). It is 
interesting that (1) certain genotypes of several IL6 gene 
SNPs appear to be beneficial in healthy individuals regard-
ing muscle damage response, but are disadvantageous 
in chronic disease and ageing; (2) sex-specific genotype 
associations with exercise-induced muscle damage have 
been reported (Devaney et al. 2007; Sprouse et al. 2014). 
Further investigations are necessary to uncover genotype–
phenotype interactions and, in particular, the interaction of 
specific polymorphisms. A specific polygenic profile might 
help to explain the inter-individual variance in the response 
to both acute eccentric damaging exercise and chronic 
strength training.
Moreover, the ACTN3 R577X SNP has been associ-
ated with different responses to muscle damaging exercise, 
according to the mode of damaging exercise. It is likely 
that stretch–shortening cycle-related movements place dif-
ferent demands on the musculotendinous system compared 
to exercises, which are performed without stretch–short-
ening cycles, thus explaining the equivocal findings con-
cerning the association between this SNP and exercise-
induced muscle damage (see “Alpha-actinin-3 R577X 
polymorphism and the initial phase of exercise-induced 
muscle damage”). Consequently, we recommend that 
future studies distinguish between exercise-induced muscle 
damage caused by eccentric contractions with or without 
stretch–shortening cycles. Furthermore, real-world modes 
of exercise should be incorporated into studies investigat-
ing the genetic association with exertional muscle damage 
in both young and older people. Not only will this improve 
our understanding of the mechanisms underpinning the 
deteriorated response of ageing muscle to exercise, but also 
it will help in prescribing more practical exercise therapies 
to poor exercise responders, young or old.
Conclusions
Understanding the causes and consequences of these 
genetic associations with exercise-induced muscle dam-
age may eventually allow the identification of individu-
als, who are at high-risk of developing specific injuries. 
For instance, those who are genetically more predisposed 
to muscle damage, and who require longer recover from 
strenuous exercise, are at greater risk of developing over-
use injuries. Knowing how someone is likely to respond 
to a particular type of exercise would help coaches tailor 
the training and nutrition of their athletes (moving from 
a one size fits all to an individualised approach), thus 
maximising recovery and positive adaptation, and reduc-
ing the risk of injury. It would also help general practi-
tioners prescribe personalised exercise medicine to older 
individuals, who may normally be prescribed resistance 
type training to counter the effects of sarcopenia, but are 
already at a higher risk of suffering from exercise-induced 
muscle damage due to chronically elevated systemic 
inflammation.
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